Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Anti-Cancer Drugs
|
August 18, 2021
Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44
Weiyi Wang, Mengzhao Zhang, Zhixin Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 12, 2020
Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway
Cancan Zhou, Jie Li, Weikun Qian, et al.
Oncology Reports
|
June 27, 2025
[Corrigendum] 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer
Shiqi Wu, Jun Huang, Ke Hui, et al.
International Journal of Oncology
|
March 1, 2019
Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
Zhixin Huang, Mengzhao Zhang, Guanqiu Chen, et al.
Oxidative Medicine and Cellular Longevity
|
March 10, 2020
NLRP3 Inflammasome and Inflammatory Diseases
Zheng Wang, Simei Zhang, Ying Xiao, et al.
Current Cancer Drug Targets
|
June 2, 2020
Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives
Simei Zhang, Wunai Zhang, Ying Xiao, et al.
Oncology Reports
|
September 19, 2018
2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer
Shiqi Wu, Jun Huang, Ke Hui, et al.
Cell Death & Disease
|
May 9, 2020
MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma
Yangyang Yue, Ke Hui, Shiqi Wu, et al.
Journal of Cellular and Molecular Medicine
|
July 8, 2020
Positive feedback in Cav-1-ROS signalling in PSCs mediates metabolic coupling between PSCs and tumour cells
Shan Shao, Tao Qin, Weikun Qian, et al.
Cellular Signalling
|
April 24, 2021
MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling
Shiqi Wu, Yangyang Yue, Yanan Gu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Anti-Cancer Drugs
|
August 18, 2021
Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44
Weiyi Wang, Mengzhao Zhang, Zhixin Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 12, 2020
Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway
Cancan Zhou, Jie Li, Weikun Qian, et al.
Oncology Reports
|
June 27, 2025
[Corrigendum] 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer
Shiqi Wu, Jun Huang, Ke Hui, et al.
International Journal of Oncology
|
March 1, 2019
Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
Zhixin Huang, Mengzhao Zhang, Guanqiu Chen, et al.
Oxidative Medicine and Cellular Longevity
|
March 10, 2020
NLRP3 Inflammasome and Inflammatory Diseases
Zheng Wang, Simei Zhang, Ying Xiao, et al.
Current Cancer Drug Targets
|
June 2, 2020
Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives
Simei Zhang, Wunai Zhang, Ying Xiao, et al.
Oncology Reports
|
September 19, 2018
2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer
Shiqi Wu, Jun Huang, Ke Hui, et al.
Cell Death & Disease
|
May 9, 2020
MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma
Yangyang Yue, Ke Hui, Shiqi Wu, et al.
Journal of Cellular and Molecular Medicine
|
July 8, 2020
Positive feedback in Cav-1-ROS signalling in PSCs mediates metabolic coupling between PSCs and tumour cells
Shan Shao, Tao Qin, Weikun Qian, et al.
Cellular Signalling
|
April 24, 2021
MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling
Shiqi Wu, Yangyang Yue, Yanan Gu, et al.
Page
of 4